Ildong to market Niaspanor in Korea

Ildong Pharm and Abbott Korea has recently announced that the two companies have signed an agreement to let Ildong Pharm market Niaspanor (nicotinic acid) as an exclusive basis here, while Abbott Korea retains its license and marketing right.

Prolonged release nicotinic acid was mentioned as a potent HDL raiser with safety profile.

Niaspanor has been shown to be highly effective in raisin...